Lannett Company, Inc. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Lannett Company with three other
companies in this sector in the United States:
Swedish Orphan Biovitrum AB (publ)
sales of $524.18 million
of which 41%
was Haemophilia: Elocta),
of which 100%
was Human Health), and
Emergent BioSolutions, Inc.
During the year ended June of 2016, sales at
Lannett Company were $566.09 million.
increase of 39.1%
versus 2015, when the company's sales were $406.84 million.
This was the fifth consecutive year of sales increases at Lannett Company
(and since 2011, sales have increased a total of 430%).